In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA Correspondence to Professor Grant L Iverson, Department of Physical Medicine and Rehabilitation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback